CTRI/2021/10/037684已完成未知
An Open Label, Prospective, Randomised, Comparative, Two Arm Clinical Study to Evaluate the Safety, Effectiveness and Tolerability of ââ?¬Å?Herbecht Hair Oilââ?¬? in Treating Alopecia and Premature Graying of Hair in Adult Subjects.
Mr Dileep Kumar0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Adult Subjects aged between 18 and 35 years old -both ages and all sexes inclusive-
- •2. Subjects with active Alopecia and Premature Graying of Hair
- •3. Subjects with a minimum hair length of 2 inches and willing to maintain the minimum length, hair style until end of study
- •4. Subjects who are willing to refrain from undergoing any hair treatments not limited to hair spa, dyeing, perming, straightening, keratin treatment or any other cosmetic treatments.
- •5. Subjects who are willing to give informed consent for participation, able to comprehend and understand the responsibilities during screening and treatment period.
- •6. Subjects who are willing not to participate in any other clinical trial during participation in the current trial.
排除标准
- •1. Subjects on topical treatments for alopecia and premature graying of hair for 8 weeks prior to enrolment.
- •2. Subjects with alopecia areata or other disorders or complications that lead to unusual hair fall or balding.
- •3. Subjects who are naturally or genetically balding or bald.
- •4. Subjects who have used hair dye in the last 30 days or intend on regular use of hair dye during the course of the study.
- •5. Subjects with other dermatological disorders of the scalp that might interfere with the study evaluation.
- •6. Subjects with significant scalp scarring
- •7. Subjects with known history of anemia or iron deficiency
- •8. Subjects with history of systemic malignancy or evidence of immunocompromised state of any type less than 5 years at the time of screening
- •9. Subjects who are planning a pregnancy and or currently breastfeeding.
- •10. Subjects who are currently enrolled in an active investigational study or have participated in an investigational study within 30 days prior to enrolment.
- •11. Any significant medical condition -e.g., significant psychiatric or neurological disorders, active alcohol or drug abuse, etc.-, any medical condition that is unstable or poorly controlled or other factor -e.g., planned relocation- that the Investigator felt would interfere with study evaluations and study participation.
- •12. Subjects who mentally unable to comprehend the responsibilities and adhere to the stipulations of the protocol.
- •13. Subjects, who in the opinion of the Investigator are not eligible for enrolment in the study.
研究者
相似试验
招募中
3 期
Study on Nutritional Supplement for Diabetic Patients.CTRI/2022/08/045041ichiIn Bio Sciences Pvt Ltd
已完成
不适用
Clinical Study on the Health Benefits of TT Compounded Asafoetida Powder in Adults with Diabetes Mellitus Type IICTRI/2021/07/034802Mahesh Value Products PvtLtd86
招募中
不适用
Clinical Study on Two Strains of Nichi Glucan AFO-202 and N-163 in NAFLDCTRI/2021/11/037789ichiIn Bio Sciences Pvt Ltd
已完成
不适用
Clinical Study on Ayurvedic Hair Oil and Shampoo vs Coconut Oil and Regular Shampoo to test on hair fall, dandruff of the scalp, grey hair and split ends.CTRI/2017/01/007721Ontop Pharmaceuticals Pvt Ltd42
进行中（未招募）
2 期
Clinical Study to Test Effectiveness of COSMA Gaming Software on Dementia PatientsCTRI/2019/10/021800Cerebrum Matter Limited